Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AQB - AquaBounty Technologies, Inc.

Previous close
0.716
-0.014   -1.955%

Share volume: 119
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.33%

PREVIOUS CLOSE
CHG
CHG%
$0.73
-0.01
-1.92%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
11%
Profitability 0%
Dept financing 3%
Liquidity 69%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
24.93%
1 Month
-26.66%
3 Months
-38.98%
6 Months
-55.45%
1 Year
-68.97%
2 Year
-94.81%
Key data
Stock price
$0.72
P/E Ratio 
-0.05
DAY RANGE
$0.67 - $0.69
EPS 
-$19.11
52 WEEK RANGE
$0.56 - $3.00
52 WEEK CHANGE
-$75.22
MARKET CAP 
3.962 M
YIELD 
N/A
SHARES OUTSTANDING 
3.866 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.97
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,977,341
AVERAGE 30 VOLUME 
$1,138,566
Company detail
CEO: Sylvia A. Wulf
Region: US
Website: aquabounty.com
Employees: 100
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

AquaBounty Technologies, Inc. focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered salmon for human consumption.

Recent news